The price has been going up and down for this period, and there has been a -5.23% loss for the last 2 weeks….Predicted Opening Price for Catalyst Pharmaceuticals of Friday, December 3, 2021.
| Fair opening price December 3, 2021 | Current price |
|---|---|
| $6.99 | $7.06 (Overvalued) |
Is Cprx a buy?
Catalyst Pharmaceuticals has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
What does Catalyst Pharmaceuticals Inc do?
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company. The Company is focused on in-licensing, developing, and commercializing medicines for patients living with rare diseases. The Company is developing a pipeline of medicines for other rare diseases.
What does Catalyst Pharmaceuticals make?
biopharmaceutical
Catalyst Pharmaceuticals is a biopharmaceutical company based in Coral Gables, Florida….Catalyst Pharmaceuticals.
| Type | Public company |
|---|---|
| Products | Firdapse® (amifampridine) Tablets 10 mg (commercialized 2019) |
| Operating income | US$ -35 million (2018) |
| Total assets | US$ 60.5 million (2018) |
Does CPRX stock pay dividends?
CPRX does not currently pay a dividend.
When did Catalyst Pharmaceuticals go public?
Announces Public Offering of Common Shares and Warrants. CORAL GABLES, Fla. , Oct. 28, 2011 (GLOBE NEWSWIRE) — Catalyst Pharmaceutical Partners, Inc.
Does Cprx stock pay dividends?
Is pharmaceutical catalyst ethical?
Catalyst Pharmaceuticals is an organization based on strong values of responsibility and integrity. Our Code of Conduct contains general guidelines for conducting business with the highest standards of ethics.
Is Catalyst Pharmaceuticals a good stock?
Valuation metrics show that Catalyst Pharmaceuticals, Inc. may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of CPRX, demonstrate its potential to outperform the market.
What is Catalyst stock market?
A catalyst in the markets can be anything that leads to a drastic change in a stock’s current price trend. The most common catalysts come in the form of new, often unexpected, information that causes the market to reevaluate a company’s business prospects.
What is catalyst stock market?
What is the price of cprx stock?
One share of CPRX stock can currently be purchased for approximately $4.97. How much money does Catalyst Pharmaceuticals make? Catalyst Pharmaceuticals has a market capitalization of $511.80 million and generates $119.07 million in revenue each year.
What is it like to work with cprx?
I have found the Physical Therapists at CPRx to be very knowledgeable professionals who effectively covey their knowledge into physical training exercises that their clients can understand. Their trainers are very personable and quickly put their clients at ease.
Can catcatalyst (cprx) beat earnings expectations?
Catalyst (CPRX) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
